RETATRUTIDE 10 MG - TRIPLE AGONIST

Retatrutide 10MG is an investigational peptide studied for its multi-receptor activity across GLP-1, GIP, and glucagon receptors. This triple-pathway signaling profile makes it a valuable tool for research into endocrine feedback mechanisms, energy regulation networks, and multi-hormonal metabolic signaling.

Each vial contains 10MG of lyophilized Retatrutide with >99% purity, manufactured under sterile, research-grade conditions as part of the Hudson Science Premier Peptide Line. All batches are independently verified by third-party laboratories for molecular identity, peptide integrity, and batch consistency, supporting long-term and multi-phase experimental protocols.

Retatrutide is used in non-clinical models to investigate incretin-glucagon receptor interactions, nutrient-sensing pathways, and hormonal feedback loops related to energy utilization. Its multi-receptor activity enables deeper exploration of coordinated peptide signaling compared to single-pathway analogs, providing insight into systemic endocrine regulation and inter-pathway communication.

This peptide is also applied in comparative research with other incretin-based compounds, such as tirzepatide and semaglutide, to evaluate differences in receptor selectivity, metabolic pathway activation, and cross-regulation of GLP-1, GIP, and glucagon signaling networks.